Zoekresultaten - Nicholas K. Mollanazar, MD

Dupilumab for the treatment of pityriasis lichenoides chronica door Charissa N. Obeng-Nyarko, MS, Kevin Puerta Durango, BS, BA, Shanelle Jackson, BS, Olaf Rodriguez, MD, Nicholas K. Mollanazar, MD, MBA

Connect to this object online.

Resolution of acquired palmoplantar keratoderma and scurvy after treatment of multivitamin deficiencies door Corbett T. Berry, MD, PhD, Katarina G. Berry, MS, RD, LDN, James Abbott, MD, Angela J. Jiang, MD, Lukas Ronner, MD, MSc, Nicholas K. Mollanazar, MD, Robin Canada, MD, Douglas J. Pugliese, MD, MPH, Temitayo A. Ogunleye, MD

Connect to this object online.

Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)Capsule Summary door Gil Yosipovitch, MD, Brian S. Kim, MD, Shawn G. Kwatra, MD, Nicholas K. Mollanazar, MD, Sonja Ständer, MD, Takahiro Satoh, MD, PhD, Pedro Mendes-Bastos, MD, Tsen-Fang Tsai, MD, Elizabeth Laws, PhD, Michael C. Nivens, PhD, Jennifer Maloney, MD, Genming Shi, PhD, Ashish Bansal, MD, MBA, Ariane Dubost-Brama, MD

Connect to this object online.